For the Inventor, By the Inventor

Enter assignee name

Watertown, MA, United States of America

Tetraphase Pharmaceuticals, Inc.

USPTO Granted Patents = 18

% Expired Patents = 38.9

CIPO Patents = 3

EPO Patents = 10

Trademarks = 3

Forward Citations = 97

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Minsheng He (12 out of 28 patents)

Xiao-Yi Xiao (12 out of 35 patents)

Roger B Clark (11 out of 22 patents)

4. Louis Plamondon (9 out of 28 patents)

5. Magnus Ronn (7 out of 11 patents)

6. Diana Katharine Hunt (7 out of 7 patents)

7. Cuixiang Sun (6 out of 7 patents)

8. Wu-Yan Zhang (6 out of 6 patents)

9. Danny LaFrance (5 out of 5 patents)

10. Chi-Li Chen (5 out of 9 patents)

11. Jingye Zhou (4 out of 17 patents)

12. Magnus Rönn (4 out of 4 patents)

13. Robert Zahler (3 out of 74 patents)

14. Philip C Hogan (3 out of 3 patents)

15. Yansheng Liu (3 out of 3 patents)

18 patents: Sort by Forward Citations

1. 12570604 - Polymorphic forms of a tetracycline compound and uses thereof (2026-03-10),

2. 12269807 - Crystalline forms of eravacycline (2025-04-08),

3. 11578044 - Crystalline forms of eravacycline (2023-02-14),

4. 10961190 - Crystalline forms of eravacycline (2021-03-30),

5. 10913712 - Tetracycline compounds (2021-02-09),

6. 10618879 - Semi-synthesis procedures (2020-04-14),

7. 10315992 - Tetracyline compounds (2019-06-11),

8. 10087157 - Semi-synthesis procedures (2018-10-02),

9. 10072007 - Tetracycline compounds (2018-09-11),

10. 9624166 - Tetracycline compounds (2017-04-18),

11. 9573895 - Tetracycline compounds (2017-02-21),

12. 9371283 - Polycyclic tetracycline compounds (2016-06-21),

13. 9315451 - Tetracycline compounds (2016-04-19),

14. 8906887 - C7-fluoro substituted tetracycline compounds (2014-12-09),

15. 8828988 - 8-AZA tetracycline compounds (2014-09-09),

Tetraphase Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel antibiotics for the treatment of serious and life-threatening infections. With a robust pipeline of potential products, Tetraphase is committed to addressing the growing global health threat of antibiotic resistance. Their innovative approach combines chemistry and microbiology to create potent, differentiated antibiotics that target drug-resistant bacteria. Leveraging their expertise, Tetraphase aims to improve patient outcomes and contribute to the fight against antibiotic resistance.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

18 Patents

#24 in Watertown, MA

#1,097 in Massachusetts

#17,922 in US

#34,120 in the World

Watertown, MA, United States of America

Tetraphase Pharmaceuticals, Inc.

Forward Citations = 97

19 inventors:

Minsheng He (12 out of 28 patents)

Xiao-Yi Xiao (12 out of 35 patents)

Roger B Clark (11 out of 22 patents)

4. Louis Plamondon (9 out of 28 patents)

5. Magnus Ronn (7 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…